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1. Introduction 
As defined in the 4th edition of Diagnostic and Statistical Manual of Mental Disorders 
(American Psychiatric Association, 1994), Attention deficit hyperactivity disorder (ADHD) 
is characterized by a persistent pattern of inattention, hyperactivity, and impulsiveness, 
though it can present with or without hyperactivity. ADHD is the most common childhood 
mental health disorder, with an estimated prevalence of 7% to 10% in boys and 3% in girls 
aged 4-11 years (Sgrok et al., 2000). This disorder substantially affects the individual’s 
normal cognitive and behavioral functioning. For example, children with ADHD can have a 
great deal of difficulty focusing on lessons presented by their teachers and remembering 
how to do their homework. They may often be easily distracted whereby they pay attention 
to other things than what they should. 
The numerous studies support a model that defines ADHD as an inherited disorder whose 
core symptoms are founded in neuroanatomic, neurochemical, and neurophysiologic 
abnormalities of the brain (Monastra, 2005). Deficits associated with ADHD support a 
hypothesis that anatomical and biochemical abnormalities of the prefrontal cortex constitute 
the physical basis of this disorder (Barkley, 1997). In this line, neurodiagnostic procedures 
(e.g., positron emission tomography [PET], single photon emission tomography [SPECT] 
and magnetic resonance imaging [MRI]) studies have provided evidence of the neurological 
basis of ADHD (Boutros, et al., 2009). Nevertheless, new theories on the pathogenesis of 
psychopathological phenomena conceptualize as a consequence of the failure to integrate 
the activity of different brains' areas (Boutros et al., 2009). It needs techniques tapping the 
dynamics of complex interaction over time among cerebral regions involved in the 
integration of cognitive processing. 
Electrophysiological techniques enable monitoring brain processing in real time, providing the 
best methods to describe the time course of brain electrical activities. Growth of this field came 
from the newer and quantifiable techniques such as quantitative electroencephalography 
(QEEG). QEEG methods provide a set of non-invasive tools that are capable of quantitatively 
assessing resting and evoked activity of the brain with sensitivity and temporal resolution 
superior to those of any other imaging methods (Hughes & John, 1999).  
QEEG studies have explored brainwave profile in children with ADHD, compared to 
normal children.  These brainwaves could be trained via operant conditioning (called EEG 
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biofeedback or neurofeedback) and it is claimed that self regulation of brain electrical 
activity result in a therapeutic benefit in ADHD. The main purpose of this chapter is to look 
at one alternative method of treating children with ADHD. To fulfill this purpose, the 
present chapter will review: 
 description of electroencephalography and QEEG 
 QEEG findings in ADHD 
 brief history and rationale for neurofeedback development 
 description of neurofeedback in practice 
 neurofeedback findings in the treatment of ADHD as supported by controlled studies. 
Our brain is made up of many cells, including neurons and glial cells. There are about 100 
billion neurons in the brain. Neurons are cells that send and receive information to and from 
the brain and nervous system. The language of these communications throughout the 
nervous system is electro-chemical signals. An electroencephalography (EEG) is a tool for 
measuring electrical activity generated in the brain. These electrical activities of neurons are 
very tiny. Hence, EEG activity always reflects the summation of the synchronous activity of 
thousands or millions of neurons; when many neurons shift towards being more ready to 
fire (excitatory) or to not fire (inhibitory) at the same time. The EEG signals are recorded 
using sensors (electrodes) placed on the scalp. Electrodes are attached to our head and 
hooked by wires to a computer and then the computer records our brain's electrical activity 
on the screen. Patterns of neuronal electrical activity recorded are called brainwaves. 
An EEG signal is characterized by three major components: phase, frequency and 
amplitude. Traditional EEG displays waveforms in the time domain, and the interpretation 
is based on amplitude and dominant frequency. Each brainwave frequency is expressed in 
Hertz (Hz). One Hz means 1 cycle per second; it is the rhythm of the wave. Amplitude 
represents the height (intensity) of the brainwave, and is expressed in microvolt (mV). 
Brainwaves have traditionally been separated into different frequency bands (Drongelen, 
2007): 
 Delta rhythm (ǅ): 0.1–4 Hz 
 Theta rhythm (θ): 4–8 Hz 
 Alpha rhythm (ǂ): 8–12 Hz 
 Sensory-motor rhythm (SMR): 12 to 15 Hz 
 Beta rhythm (ǃ): 15–30 Hz 
 Gamma rhythm (Ǆ): the higher EEG frequencies, usually 30~70 Hz. 
Conventional interpretation of the EEG is done visually by a trained specialist. The specialist 
will examine the EEG, by detecting features of waveshapes (morphology) of the brainwaves 
to identify certain characteristics that might indicate organic or neurological pathologies. 
Routine EEG is typically used in the following clinical circumstances: 
 to distinguish epileptic seizures, 
 to differentiate "organic" encephalopathy or delirium from primary psychiatric 
syndromes such as catatonia,  
 to serve as an adjunct test of brain death, 
 to localize the region of brain from which a seizure originates (Niedermeyer and da 
Silva, 2004). 
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A voluminous literature attests to the robustness of conventional EEG studies and their 
clinical utility in disorders of brain function (Hughes & John, 1999). However, many 
functional characteristics of brain activity could not be detected visually. Whereas, 
quantitative EEG (QEEG) transform the EEG into a format or domain that elucidates 
relevant information, or associate numerical results with the EEG data for subsequent 
review or comparison (Nuwer, 1997). Often, neurologically based disorders do not involve a 
structural abnormality, lesion, or disease process, but abnormalities are expressed in the 
way the brain evaluates information. These processes can be studied with QEEG techniques, 
but not with simple visual analysis of the raw EEG (Hoffman et al., 1999). Hence, one can 
say that QEEG might provide additional measurements and displays of EEG in many 
different ways that are not possible with visual inspection. 
In fact, QEEG reflects the ability of a network to locally synchronize. Such ability to 
synchronization is related to the integrative capacities of a network and to the characteristics 
of its inputs. This can be strongly modified by the active state of the brain. Thus, impairment 
of cognitive processing (i.e. attention) can be monitored by QEEG (Nazari, 2008). 
Furthermore, QEEG enables precise comparison of the individual patient's record with 
normative and psychopathologic patient databases (Hughes & John, 1999). QEEG 
procedures involve the mathematical processing of digitally recorded EEG. The most 
commonly used method for EEG quantification is the spectral analysis by means of Fast 
Fourier Transformation (FFT) algorithm. It provides measures of the power at each 
frequency of the EEG bands, known as the power spectrum. The test-retest of power spectra 
has been shown to be high (Hughes & John, 1999). 
The first step for doing a QEEG is digital EEG recording; a cap (usually 19 electrodes at 
standardized positions) placed on the head and two electrodes are placed on the ears. The 
electrodes are then made to conduct with the scalp and ears by using a conductive gel. Once 
this is achieved, a computer interfaces with the EEG machine, and a software program is 
used to display the traces of the brainwaves generated by the brain, and detected on the 
scalp. Data is recorded during resting states of eyes open, eyes closed, and in some instances 
during cognitive tests such as reading or attentional task. Approximately ten minutes of 
data are recorded in each state. A QEEG typically requires about an hour total in the clinic to 
complete the data gathering.  
After recording the EEG data it is edited to remove artifacts which are distortions in the EEG 
signal due to muscle movement such as coughs, eye movement, and teeth clenching, muscle 
tension, pulse and other sources. Artifacts are electric potentials of non-brain origin that are 
in frequency and voltage range of EEG signals and that are detected by scalp electrodes 
(Boutros et al., 2009). Clinicians utilizing QEEG must be skillful in recognizing and 
minimizing artifacts, as well as in careful pre-recording preparation procedures to minimize 
artifacts in the EEG (Hammond and Gunkelman, 2001). Indeed, it needs to carefully study 
the raw EEG since abnormalities may be masked by the use of a QEEG alone (Hammond et 
al., 2004). During the editing process the data is examined visually to identify any patterns 
that might be of interest for training purposes or would suggest the need to refer to another 
specialist. 
After the editing process is completed the EEG data is subjected to a variety of mathematical 
and statistical analyses. EEG recordings should be of sufficient quality and of sufficient 
length so that after artifacting there is a minimum of 40-50 seconds of artifact-free data 
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available for analysis (Hammond et al., 2004). A sample of artifact-free EEG data, usually 1 
to 2 minutes, is analyzed, using the FFT to quantify the power at each frequency of the EEG 
averaged across the entire sample (Hughes & John, 1999). Results from each electrode can be 
represented as following measures: 
 absolute power: amount of amplitude in each band (total µV²),  
 relative power: in each band percentage of absolute power/total power,  
 power ratio: i.e. absolute power of theta/absolute power of beta (theta/beta ratio),  
 coherence: a measure of synchronization between activity in two channels (similarity of 
frequency between two channels), 
 symmetry (the ratio of power in each band between a symmetrical pair of electrodes (no 
similarity is called asymmetry). 
The final analysis is the database comparison. This procedure allows for an individual’s 
EEG to be compared to an ‘average’ EEG. One can use a reference EEG database to reveal 
the location and type of EEG feature abnormalities greater than two standard deviations 
from a normative group (Thatcher, 1998). This comparison data is derived from the analysis 
of EEG’s gathered from hundreds of individuals; same sex, same handedness, approximate 
same age; who do not exhibit or report historically any significant mental health issues. 
Often the EEG will be compared to multiple databases. The aspects of an individual’s EEG 
to be analyzed by the QEEG are:  
 Does the individual’s EEG features differ from the 'average’ EEG? 
 How does it look different (the level of statistical significance and the degree of 
difficulty)?  
 Where (what areas of the brain) does it look different? 
The QEEG data is used to generate a series of analyses presented in tables and graphics in 
brain map. Brain map is a computerized EEG topography that enables the construction of a 
bi- or three-dimensional matrix for a topographic representation of Q-EEG parameters, such 
as instant amplitude or band power (Boutros et al., 2009). Different algorithms have been 
proposed to localize underlying brain generators. Among the distributed source models, 
Low Resolution Brain Electromagnetic Tomography-LORETA (Pasqual-Marqui et al., 1994) 
has been proven to present the smallest localization error (Boutros et al., 2009). The 
LORETA is one of the QEEG topographic analysis method by which one can provide a 3-D 
analysis of the EEG identifying localized disruptions in brain activity within the interior of 
the brain.  
An individual who has received specialized training in these fields (see Hoffman et al., 1999; 
Hammond et al, 2004; Hammond et al, 2011) could examine the QEEG results. Individuals 
conducting assessment utilizing quantitative EEG or any type of brain mapping should be 
able to gather reliable data. A much higher standard is required for someone to hold himself 
or herself out as competent to analyze and interpret QEEG data (Hammond et al., 2004). It is 
strongly recommended that the QEEG providers should hold diplomate status in QEEG from 
the Quantitative Electroencephalography Certification Board or be certified by the EEG and Clinical 
Neuroscience Society (or a comparable neurology board in the case of physicians), or be analyzing 
data under the supervision of such a certified person, or at a minimum be able to demonstrate 
thorough education, training, and work product documenting their competence to interpret QEEGs. 
Otherwise, the QEEG data should be submitted for analysis by an individual with such certification 
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(Hammond et al., 2011). For further details about standards and qualifications for doing 
QEEG and neurofeedback see Hoffman et al., 1999; Hammond et al, 2004 and Hammond et 
al, 2011. 
Due to the non-invasive nature of the procedure, the convenience, not expensive, and 
specificity of the data the QEEG has been used extensively to examine a variety of aspects of 
brain function. As mentioned before, with the quantitative EEG and topographic brain 
maps, it is often possible to observe attributes of brain function that cannot be seen in the 
raw EEG signal. These processes can be observed and quantified through subtle frequency-
related and coherence related activities in the QEEG brain maps that index the degree of 
difficulty of cognitive tasks (Hoffman et al., 1999). Furthermore, it is well known that a great 
many medications as well as psychoactive drugs can produce some alteration in the EEG 
(Boutros et al., 2009). The availability of QEEG let to the development of a new research field 
that named pharmaco-EEG. Pharmaco-EEG methods were included in preclinical studies to 
identify at early stages of drug development, the therapeutic indications of new drugs, 
determining onset, peak effect, and duration of drug effect on CNS, and predict 
therapeutically useful dosage of psychotropic drugs (Boutros et al., 2009).       
In the clinical setting, many studies have been reported that QEEG can be useful for the 
evaluation and understanding of mild traumatic brain injury, learning disabilities, ADHD, 
alcoholism, depression, and other types of substance abuse (Hoffman et al., 1999). 
Specifically, QEEG studies have reported different brainwave patterns in children with 
ADHD than those of the normal population. 
Most studies of the electrophysiological correlates of ADHD have compared the QEEG from 
ADHD sufferers with those of healthy children under resting conditions (for a review, see 
Barry et al., 2003; for a meta-analysis, see Snyder & Hall, 2006). However, the allocation of 
neural resources differs when the subject directs his/her attention to an experimentally 
controlled situation (Thatcher, 1998). It is therefore important to evaluate a neural network's 
ability to change from a passive to an active condition. Since inattentiveness and 
distractibility are the major symptoms of ADHD, assessment of these symptoms would 
require tasks specifically designed to highlight attentional deficits, such as the continuous 
performance task (CPT) or the go/no-go task. Hence, in a study, Nazari et al (2011) set out 
to establish the functional reactivity of frequency-specific EEG activities during eyes-open 
resting and CPT in children with ADHD. High-resolution EEG was recorded during eyes-
open resting and CPT performance in 16 children meeting the DSM-IV criteria (APA, 1994) 
for ADHD and 16 age-matched controls. Significant CPT vs. eyes-open differences in EEG 
activities was observed in children with ADHD. In particular, switching to CPT induced an 
alpha power increase in children with ADHD and an alpha power decrease in controls. 
Lower alpha power at baseline (eyes-open resting condition) might be interpreted as 
meaning that children with ADHD are unable to attend to and process visual stimuli as 
efficiently as healthy children. Klimesch et al (1996) suggested that alpha synchronization 
during mental inactivity may be important for introducing powerful inhibitory effects, 
which could prevent a memory search from entering irrelevant parts of neural networks. 
Based on this explanation, we suggested that impaired inhibition of neural networks in 
children with ADHD at baseline alters not only energy demands but also control excitatory 
processes. Opposite alpha changes may also reflect a primary deficit associated with cortical 
hypoarousal in ADHD. These EEG results agree with behavioral findings leading the 
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authors to suggest that dynamic changes in neural network activities are impaired in 
children with ADHD (Nazari et al., 2011). 
Lubar (1995) compared QEEG data for ADHD children with controls. He concluded, 
"Excessive theta activity and lack of beta activity are the primary neurological landmarks of 
ADHD" (p. 505). Furthermore, "during academic challenges, there were significant increases 
in slow (4-8 Hertz) theta activity along the midline and in the frontal regions and decreased 
beta activity, especially along the midline posteriorly" (p. 502). Lubar's review of the 
literature revealed the following: 
"Abnormalities in EEG were reported in children now classified as ADD and ADHD as early as 
1938 (Jasper, Solomon & Bradley, 1938). There is extensive literature, much of it reviewed in the 
supplement to the Journal of Child Neurology published in 1991. Basically, EEC studies show 
excessive slow activity in central and frontal regions of the brain. These studies are supported by 
recent PET [positron emission tomography] scan and SPECT [single photon emission 
computerized tomography] scan studies that also indicate abnormalities in cerebral metabolism 
in these particular brain areas" (p. 50I). 
Based on Lubar's finding, studies have repeatedly reported a QEEG pattern that might be 
present in ADHD but not in controls (normal children, adolescents, and adults). A 
considerable number of these studies have reported an increase in low-frequency power 
(predominantly theta) and a decrease in high-frequency power (especially beta) in children 
with ADHD compared with the age-matched control group (Barry et al., 2003; Snyder & 
Hall, 2006). Some researchers have tried to examine the theta/beta ratio as a measure of 
ADHD-related abnormality with a higher detection power. As reported by Snyder & Hall 
(2006) results of 9 DSM-IV studies and the results of 29 pre–DSM-IV studies support that a 
theta/beta ratio increase is a commonly observed trait in ADHD relative to controls. By 
meta-analytic statistical extrapolation, the effect size of 3.08 predicts a sensitivity and 
specificity of 94%, which is similar to values predicted by retrospective studies examining 
ADHD and normal controls in group comparisons (Snyder & Hall, 2006). 
As emphasized by the committee of the Association for Applied Psychophysiology and 
Biofeedback (AAPB) and the Society for the Study of Neuronal Regulation (SSNR), QEEG 
should not be the only tool used for diagnosis of attention-deficit/hyperactivity disorder 
(Hoffman et al., 1999). There is no single technique that can be solely relied upon for the diagnosis. 
Manifestations of ADD/ADHD reflect behavior problems, learning style, cognitive processing, social 
interaction, and many other developmental factors. The current diagnosis of ADD/ADHD depends 
also on the use of computerized continuous performance tasks, detailed history, school performance, 
and evaluation for learning disabilities and other comorbidities, as well as other measures. QEEG 
data complement these other findings by providing for a comparison of brain activity with databases 
for both normal and ADD/ADHD groups (Hoffman et al., 1999). 
Having diagnosed the locations in the brain that are producing high or low activity, it is 
now possible to intervene with training the brain to normalize the activity of the various 
locations in the brain. On the other words, the power in being able to define deviations of 
brain’s electrical patterns within a normally distributed measurement set is that one can 
target deviant measures to “normalize” by a variety of intervention modalities. In fact, the 
EEG (as a physiological measure) is considered a form of behavior, which is subject to 
behavior modification through basic "operant conditioning" and "shaping" principles within 
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the formwork of learning theory. This brainwave training and learning self regulation of 
brain activity is called EEG biofeedback or neurofeedback. Neurofeedback postulates that 
normalizing the target signal will result in a therapeutic benefit. Definition of neurofeedback 
by the International Society for Neurofeedback and Research (ISNR) is the following:  
"neurofeedback is a process in which sensors are placed on the scalp and devices are used to 
monitor and provide moment-to-moment information that is fed back to the individual about his 
or her physiological brain activity for purposes of improving brain functioning" (Hammond et 
al., 2001; p.55). For detailed information about neurofeedback see the website of the 
ISNR (http://www.isnr.org). 
Figure 1 shows the neurofeedback procedure. During neurofeedback training, 
neuroelectrical activity is detected via surface electrodes (step 1). Note that no electrical 
current is put into the brain. This activity is then amplified (step 2) and processed by 
software programs (step 3) that provide contingent auditory or visual feedback to the 
patient on a computer monitor (step 4); brain activity is monitored and desired changes are 
rewarded similar to a videogame. The patient watches the dynamic display of the amplitude 
of the brainwaves in the areas where the electrodes are attached by a gel paste. The 
computer program gives a reinforcement each time the goal level of the EEG power (an 
optimal brain state) is reached. This processing continues during the neurofeedback session 
for a period of 15 to 40 minutes (step 5). 
 
Fig. 1. Neurofeedback procedure 
For example, there might be areas of the brain where there is an excess of neurons firing 
slowly during tasks requiring concentration. This is often the case with ADHD. On the basis 
of QEEG findings in ADHD, typically the EEG of a person with ADHD will reveal excess 
theta activity, but diminished beta activity. Hence, during the neurofeedback training a 
puzzle advances and sounds a tone whenever a child with ADHD maintains waves in the 
15-18 Hz range above a certain amplitude threshold (beta increasing) while keeping waves 
in the 4-8 Hz range below a certain threshold (theta decreasing). Clients require 20 to 60 
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training sessions to achieve their goals. Training takes place 1-3 times for at least one hour of 
training per week. Once the original goals of treatment have been met, the client continues 
to train for an additional 5 to 10 sessions to prevent relapse (Demos, 2005).         
Prior to beginning neurofeedback training an assessment is conducted to examine 
presenting problems, client history, contributing factors, current medications the patient 
may be taking, and other relevant information. Interviews, symptom checklists, computer 
based tests (i.e. CPT, TOVA, IVA), and review of relevant documentation are common 
components of the assessment. A pre- and post treatment objective assessment of the client’s 
QEEG should be performed. The QEEG objectively assess the functioning of the brain in 
comparison with normative database (Hammond et al., 2011). One can use QEEG database 
and topographical brain maps to evaluate the location and type of EEG feature to target for 
neurofeedback training. 
After reviewing the data gathered during the assessment a training protocol is developed. 
The neurofeedback protocols cover the following questions: 
 Power of which frequency bandwidth targeted to be changed? 
 Which areas of the brain are to be trained (electrodes location)? 
 Which montage must be used (referential or bipolar)? Which locations are chosen for 
active electrode, reference and ground? 
 How threshold levels are set for each client? 
The rationale for neurofeedback protocols is based on solid research and clinical practice. 
Initially, neurofeedback treatments for ADHD are founded on the groundbreaking research 
conducted by Sterman (roth et al., 1967; sterman and Wyrwicka, 1967; Wyrwicka and 
sterman, 1968; sterman et al., 1969 and Lubar and Shouse, 1976; Lubar and Lubar, 1984). A 
brief history could be interesting. Sterman’s research team conducted a systematic 
examination of EEG patterns and identified the sensory motor rhythm-SMR (12 -15 Hz) over 
the Rolandic cortex. They were able to train cats to increase production of this rhythm by 
providing food as an immediate reward. In later research those cats exhibited a significant 
improvement in stability when exposed to Hydrazine observed to evoke seizure activity in 
cats that had not received the SMR increasing. Subsequently, they demonstrated that 
patients with seizure disorders could develop improved control over epileptiform activity 
by learning self-regulation of the SMR (Sterman, 2000).  
Sterman’s procedure was replicated by Lubar who used the same training to reduce the 
symptoms exhibited by ‘hyperkinetic’ children. Initially, Lubar and Shouse (1976) reported 
some improvements in a hyperactive child who had learned to reduce theta and increase 
production of SMR. Subsequently, Lubar and Lubar (1984) reported that children diagnosed 
with an attention deficit disorder demonstrated improved attention and behavioral control 
after being trained to increase production of EEG activity in a fast frequency range (beta) 
while learning to suppress slow wave activity (theta).  
These two primary training approaches provide the foundation for each of the protocols that 
have been examined in the controlled group studies of neurfeedback for ADHD. In a review 
study, Monastra (2005) has summarized three neurofeedback protocols that have been 
investigated in controlled group studies. These research-based protocols are the following 
(Monastra, 2005): 
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Protocol 1- SMR enhancement/theta suppression: in this protocol, patients (ADHD who 
present with primary symptoms of hyperactivity and impulsivity) instructed to increase 
their SMR (12–15 Hz) over one of two sites (C3 or C4) while simultaneously suppressing 
the production of theta (4–7 or 4–8 Hz) activity. EEG recordings are obtained from one 
active site, referenced to linked earlobes. Auditory and visual feedback is provided based 
on patient success in controlling power of theta below and SMR above pretreatment 
thresholds. 
Protocol 2- Theta suppression/beta1 enhancement: In this protocol, patients are reinforced 
for increasing production of beta1 activity (16–20 Hz) while suppressing theta activity (4–8 
Hz). Recordings are obtained at Cz with linked ear references, at FCz-PCz with single ear 
reference, or at Cz-Pz with ear reference. A variation of this protocol also has been reported 
in the treatment of ADHD, predominately inattentive type (Fuchs et al., 2003). In this 
training protocol, theta suppression and beta enhancement are reinforced at C3.  
Protocol 3- SMR enhancement/beta2 suppression: in this protocol, children with ADHD, 
predominately hyperactive/impulsive type, are trained to increase SMR (12–15 Hz) while 
suppressing beta2 activity (22–30 Hz) (Fuchs et al., 2003) Recordings are obtained at C4 with 
linked ear reference. In ADHD, combined type, this protocol is used during half of each 
session. During the other portion of each training session, SMR enhancement/theta 
suppression at C3 is used. Selection of a neurofeedback protocol should be based on level of 
experience and training, accreditation, the fraction of the therapist’s practice devoted to 
neurofeedback, reports from clients and objective assessments, and the therapist’s specific 
experience in treating AD/HD (for more information see Monastra, 2005; Demos, 2005; 
Hammond et al., 2011). 
Since the work of Lubar and Shous (1976), numerous studies have used neurofeedback 
approaches for treating ADHD and reported successful diminution of inattentivity and 
hyperactivity, and improvement in academic performance and concluded that despite some 
limitations, neurofeedback may be worthy of further consideration as a viable treatment 
approach for ADHD (Shouse and Lubar , 1979; Lubar and Lubar, 1984; Lubar et al., 1995; 
Rossiter and La Vaque, 1995; Linden et al., 1996; Thompson and Thompson, 1998; Kaiser 
and Othmer, 2000; Carmody et al., 2001; Monastra, 2002; Fuchs et al., 2003; Heywood and 
Beale, 2003; Cho et al., 2004; Heinrich et al., 2004; Rossiter et al., 2004; Xiong et al., 2005; 
Kropotov et al., 2005; Beauregard and Levesque, 2006; Levesque et al., 2006; Strehl et al., 
2006; Gevensleben et al., 2010; Nazari et al., 2011; for review see Rossiter, 2004; ; Vernon et 
al., 2004; Monastra, 2005; Butnik, 2005; Friel, 2007; Toplak et al., 2008; John and Prichep, 
2009; Coben and Evans, 2011). In an excellent meta-analytic study, Arns et al (2009) 
investigated results of 15 controlled studies. They concluded that neurofeedback treatment 
for ADHD can be considered "efficacious and specific" with a high effect size for inattention 
and impulsivity and a medium for hyperactivity (Arns et al., 2009).  
Gevensleben et al (2009) conducted a randomized controlled trial encompassing 102 
children with ADHD. In this trial behavioral and neurophysiological effects of 
neurofeedback, were analyzed in comparison to a computerised attention skills training (as 
a semi-active control group). They have shown neurofeedback to be superior to control 
group (Gevensleben et al., 2009). They reported follow-up behavioral data assessed 6 
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months after completion of the training (either neurofeedback training or attention skills 
training). Improvements in the neurofeedback group at follow-up were superior to those of 
the control group and comparable to the effects at the end of the training. They concluded 
that "though treatment effects appear to be limited, the results confirm the notion that 
neurofeedback is a clinically efficacious module in the treatment of children with ADHD" 
(Gevensleben et al., 2010). 
In a clinical outcome study, Nazari et al (2011) investigated whether neurofeedback compared 
to methylphenidate achieves an equally effective outcome. Participants were 39 children: 13 
children with ADHD were trained to enhance the amplitude of the beta1 activity and decrease 
the amplitude of the theta activity, 13 of which were treated with methylphenidate alone, and 
13 healthy children did not receive intervention. Several behavioral, neuropsychological and 
experimental tests were administered before and after intervention. While behavioral 
measures were improved by both types of method, methylphenidate was significantly more 
effective than neurofeedback. Response inhibition (assessed by Stroop) was improved only by 
neurofeedback. Both neurofeedback and methylphenidate were associated with improvements 
on the variability and accuracy measures of computerized attention tests. Intellectual ability 
(measured by full version of WISC-III) increased also by both methods. Although averaged 
effect size for methylphenidate seems to be greater than for neurofeedback, the difference was 
not significant. In conjunction with other studies they concluded that neurofeedback can 
significantly improve several behavioral and cognitive functions in children with ADHD and 
it might be an alternative treatment for ADHD, particularly for those their parents favor a non-
pharmacological treatment (Nazari et al., 2011). 
Neurofeedback is contraindicated with subjects under age six years, or subjects with mental 
retardation, developmental delay or other significant medical, neurological, or psychiatric 
disease. Subjects from families with significant marital discord that could interfere with 
participation in the treatment process (Friel, 2007). 
Side effect can sometimes occur during neurofeedback and practitioners should be aware that 
occasionally negative effects may occur (Hammond & Kirk, 2008; Hammond et al., 2001; Lubar 
& Shouse, 1976; Todder et al., 2010) if training is not being supervised by a knowledgeable and 
certified professional. Adverse effects that have been reported by some clinicians include 
increased anxiety and agitation, headaches, fatigue, sleep disturbance, anger and irritability, 
crying and emotional lability, enuresis, an increase in depression, increase in somatic 
symptoms (including tics and twitches), seizures, and temporary disorientation. These reports 
are uncontrolled case reports from which one cannot know the degree to which other 
confounding events in the patients’ lives may have contributed to these negative symptoms 
(Hammond & Kirk, 2008). However, neurofeedback provider as a health-related profession 
should promote the welfare of their clients. Therefore, they should perform appropriate and 
objective assessments prior to, during and after providing neurofeedback to assess regularly 
the effectiveness of the services provided, and they inquire frequently about any side effects or 
adverse reactions. When it is observed that side effects or negative effects are occurring, 
providers document the details, discuss them with the client, and take appropriate action to 
remediate negative effects as quickly as possible. Such action may include modifying 
neurofeedback protocols, verifying the amount or frequency of treatment, utilizing adjunctive 
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treatments, and seeking consultation (Hammond et al., 2011). It should be mentioned that 
patients with a history of epilepsy should only receive neurofeedback from practitioners who 
are well versed in neurofeedback for seizure disorders. 
Some people interested in alternative health react to the neurofeedback with hesitation. 
Neurofeedback has been considered as a relatively unstudied treatment, and the studies that 
have been conducted have reportedly been problematic, due to methodological problems 
such as confounded treatments, inconsistent use of dependent measures, small sample size, 
and a lack of clinically meaningful dependent measures (Kline, Brann, & Loney, 2002; 
Waschbusch & Hill, 2003; Loo and Barkley, 2005; Holtmann and Stadler, 2006). In this line, 
there are some fundamental questions: 
 Does neurofeedback result in the intended EEG changes? 
 Is there really an effect that leads to significant modifications in cognition and behavior? 
 Could these changes be reliably linked to neurofeedback training? 
 How does it compare to the current standard of treatment? 
 Are these changes retained over time? 
 How does neurofeedback work? 
For validating purpose, some controlled studies on healthy subjects (i.e. Egner and 
Gruzelier, 2001; Egner et al., 2002; Vernon et al., 2003; Egner and Gruzelier, 2004) assessed 
specific cognitive, neuropsychological and electrocortical effects from training of specific 
frequency bands. They concluded that the modulation of specific frequency bands led to 
significant and protocol-specific effects. It seems that despite these validation works much 
remains to be done to provide a scientific basis for neurofeedback. 
It has been argued that a potential explanation of the effects of neurofeedback could be 
cognitive-behavioral training effect as well as client-therapist relationship effect since 
children are engaging in a training for often 30-50 sessions. Such concerns could be 
addressed by double-blind controlled studies. Considering the ethical problem of including 
untreated patient or patient undergoing placebo and the difficulty of conducting a double-
blind placebo controlled study in neurofeedback, some groups (Drechsler et al., 2007; 
Gevensleben et al., 2009) have still addressed these concerns by comparing neurofeedback 
group with a semi-active control group (can be considered a credible sham control). In these 
studies neurofeedback in comparison to this semi-active control group still had medium to 
large ES for inattention and impulsivity, and small to medium ES for hyperactivity (Arns et 
al., 2009).  
La Vaque and Rossiter (2001) pointed out that, rather than comparing a new treatment (e.g., 
neurofeedback) to a no-treatment placebo, it should be compared to a protocol of ‘known 
efficacy’ to determine whether such an intervention would result in an equivalent effect. 
This type of design is often referred to equivalent study (Vernon et al., 2004). Regarding the 
well established efficacy of methylphenidate, several studies have compared the effects of 
neurofeedback and methylphenidate. Results revealed that although averaged effect size for 
methylphenidate was greater than for neurofeedback, both were in medium range and the 
difference was not significant (i.e. Nazari et al., 2011). None of the studies comparing 
neurofeedback with stimulant medication used random assignment. Although self-selection 
www.intechopen.com
 
Current Directions in ADHD and Its Treatment 
 
280 
the treatment may bias these findings, self selection potentially maximizes the effects of 
expectancy in both groups. However, more studies using randomization and larger sample 
sizes are needed to investigate further how neurofeedback compares to stimulant 
medication in the treatment of ADHD. 
Several follow-up studies (Monastra et al., 2002; Strehl et al., 2006; Gani et al., 2008; 
Gevensleben et al., 2010) showed that improvements in behavior and attention turned out to 
be stable. Test results for attention and some of the parents’ ratings once more improved 
significantly. Based on these researches, it can be concluded that the clinical effects of 
neurofeedback are stable and might even improve further with time. This, in contrast to 
stimulant medication where it is known that when the medication is stopped often the 
initial complaints will come back again and recent evidence showing that temporary 
treatment with stimulant medication is not likely to improve long-term outcomes (Molina et 
al., 2009). 
Yet another domain in need of further investigation involves the theoretical basis and the 
underlying mechanisms of neurofeedback impact. Today, to understand "how does 
neurofeedback work?" is one of the most interesting and challenging tasks. It is not 
surprising that the field of neuroscience attracts a lot of researchers try to answer this 
question.   
Despite some limitations, neurofeedback may be worthy of further consideration as a viable 
treatment approach for ADHD (See Vernon, 2005; Friel, 2007; Toplak et al., 2008; Yucha and 
Montgomery, 2008; Arns et al., 2009). On the basis of currently available research results, the 
success of this therapeutic method is indicated by widespread utilization, and reports of 
carefully designed studies suggest the utility of this method (John and Prichep, 2009). EEG 
biofeedback therapy for AD/HD results in significant improvement in cognitive functioning 
for 75-85 percent of patients. It is possible that  faster and better outcomes might be achieved 
by combining other alternative therapies with EEG biofeedback (Friel, 2007). Neurofeedback 
meets the American Academy of Child and Adolescent Psychiatry criteria for clinical 
guideline for treatment of ADHD. As mentioned before, meta-analysis results of Arns and 
his colleagues (2009) demonstrated that neurofeedback treatment for ADHD can be 
considered "efficacious and specific".  
Frank H. Duffy, M.D., Professor and Pediatric Neurologist at Harvard Medical School, 
stated in an editorial in the January 2000 issue of the Journal Clinical 
Electroencephalography that the scholarly literature suggests that neurofeedback should 
play a major therapeutic role in many difficult areas:  
“In my opinion, if any medication had demonstrated such a wide spectrum of efficacy it would be 
universally accepted and widely used” (p. v). “It is a field to be taken seriously by all.” (p. vii). 
Until 2005, neurofeedback was reportedly used by more than 1500 practitioners (Butnik, 
2005) and the last years have seen a rapid growth of the field of neurofeedback in the US 
and at least 27 countries (Budzynski et al., 2009). There are more than 100 health-related 
professions in Iran that using neurofeedback in their routine clinical practice. All of them 
have been trained by the Biofeedback Foundation of Europe-BFE (www.bfe.org) instructors 
in the Paarand Specialized Center for Human Enhancement-PSCHE (www.paarand.org). 
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